Venus Remedies Limited (NSE:VENUSREM)

Venus Remedies Revenue

Venus Remedies had revenue of 1.79B INR in the quarter ending June 30, 2026, with 35.60% growth. This brings the company's revenue in the last twelve months to 8.11B, up 20.87% year-over-year. In the fiscal year ending March 31, 2026, Venus Remedies had annual revenue of 7.70B with 18.79% growth.

• Revenue (ttm): 8.11B
• Revenue Growth: +20.87%
• P/S Ratio: 2.94
• Revenue / Employee: 6.25M
• Employees: 1,298
• Market Cap: 23.89B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	7.70B	1.22B	18.79%
Mar 31, 2025	6.48B	464.37M	7.72%
Mar 31, 2024	6.01B	459.40M	8.27%
Mar 31, 2023	5.56B	-446.71M	-7.44%
Mar 31, 2022	6.00B	520.57M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error